Bifidobacterium longum infantis M-63 and Reduced Gastrointestinal Symptoms

• Occurrence and applications of CRISPR-Cas systems in bifidobacteria.

  • 2026-01-27
  • Review
  • Applied and environmental microbiology 92(1)
  • • Jiyong Shin
    • Rodolphe Barrangou

  • PubMed: 41489362
  • DOI: 10.1128/aem.01703-25

  2 Insights on

  • Reduced Gastrointestinal Symptoms

  • Moderate evidence
  • Rigorous Journal

  The study described improvements in digestive condition after intake of B. longum subsp. infantis M-63, including fewer gastrointestinal symptoms such as constipation and abdominal discomfort.

  Effect

  Beneficial

  Effect size

  Small